Docoh
Loading...

OCUL Ocular Therapeutix

APP
Utility
Ocular Implant Containing a Tyrosine Kinase Inhibitor
7 Oct 21
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
Charles D. Blizzard, Arthur Driscoll, Rami El-Hayek, Michael Goldstein, Joseph Iacona, Peter Jarrett, Timothy S. Jarrett, Erica Kahn, Zachary Lattrell
Filed: 24 Mar 21
APP
Utility
Compositions and Methods for Treating Ocular Diseases
19 Aug 21
The present invention relates to the treatment of ocular diseases in a human subject.
Charles D. Blizzard, Ankita Desai, Arthur Driscoll, Michael Goldstein
Filed: 5 Feb 21
APP
Utility
Ocular Hydrogel Tyrosine Kinase Inhibitor Implants
28 Oct 20
Provided herein are sustained-release biodegradable ocular hydrogel implants which are useful in the treatment of certain ocular conditions.
Peter Jarrett, Rami El-Hayek, Timothy S. Jarrett, Zachary Lattrell, Arthur Driscoll, Charles D. Blizzard
Filed: 23 Apr 20
APP
Utility
Hydrogel Implants for Lowering Intraocular Pressure
28 Oct 20
Provided herein are sustained release biodegradable ocular hydrogel implants which are useful for lowering ocular pressure and for treating related conditions.
Michael Goldstein, Arthur Driscoll, Charles D. Blizzard, Ankita Desai
Filed: 23 Apr 20
APP
Utility
Intracanalicular Hydrogel Inserts for the Delivery of Anesthetics
28 Oct 20
Provided herein are sustained-release biodegradable ocular hydrogel inserts which are useful in the treatment of certain ocular conditions.
Peter Jarrett, Michael Goldstein, Rami El-Hayek, Timothy S. Jarrett
Filed: 23 Apr 20
  • 1
Patents are sorted by USPTO publication date, most recent first